Skip to content

Alterations in Gait, Strength, and Power After Ruck Marching

Alterations in Gait, Strength, and Power After Ruck Marching

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05309603
Acronym
SPARTAN
Enrollment
26
Registered
2022-04-04
Start date
2022-03-21
Completion date
2023-07-21
Last updated
2023-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise, Fatigue

Brief summary

The purpose of this study is to determine change in injury risk and performance variables in males and females after walking unloaded and carrying a load with two different distributions (high-pack placement and mid-pack placement) to identify differences in injury risk

Interventions

OTHERLoaded Walking High

Walking three miles on a treadmill at a self-selected speed while wearing a backpack with weight carried high on the back

OTHERLoaded Walking Mid

Walking three miles on a treadmill at a self-selected speed while wearing a backpack with weight carried on the mid-back

OTHERWalking

Walking three miles on a treadmill at a self-selected speed

Sponsors

State University of New York at Buffalo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy, physically active individuals * 18-39 years old

Exclusion criteria

* History of musculoskeletal injury within the last six months or still under a physicians care for an injury occurring more than six month prior * History of spinal disc injury * History of cardiovascular, metabolic, respiratory, neural, or renal disease * No previous history or education of completing resistance exercise * Hypertensive or tachycardic during the screening visit (SBP \> 139 mmHg, DBP \> 89 mmHg, heart rate \> 100 bpm) * Taking medication or supplements with a known side effect of affecting physiologic responses to exercise (e.g., beta blockers, omega-3 fatty acids, statins, aspirin) * Any form of tobacco or nicotine use * A positive pregnancy test at any point in the study * Study physician discretion based on any other medical condition or medication * Gastrointestinal disease or previous surgery prohibiting internal body temperature pill use. Subjects who have any contraindication to internal body temperature pill ingestion will be given the option to insert the pill rectally (as a suppository) or use a rectal probe.

Design outcomes

Primary

MeasureTime frameDescription
Change in Oxygen ConsumptionUpon completion of 3 miles of walking, an average of 45 minutesOxygen consumption will be measured using indirect calorimetry
Increased muscular jerkUpon completion of 3 miles of walking, an average of 45 minutesJerk will be measured using accelerometers placed at the torso and ankle

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026